CD40LG and systemic lupus erythematosus: Estradiol, the most potent form of estrogen during reproductive years, has further been shown to increase markers of T-cell activation such as calcineurin and CD154 in SLE patients but not in healthy controls, reflecting heightened disease-specific sensitivity.